Sajatovic Martha, Davies Marilyn, Hrouda Debra R
Casae Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106-5000, USA.
Psychiatr Serv. 2004 Mar;55(3):264-9. doi: 10.1176/appi.ps.55.3.264.
Because about one-third of persons with bipolar illness take less than 30 percent of their medication and because nonadherence is associated with rehospitalization and suicide, the literature was searched to identify controlled studies of enhancement of treatment adherence among persons with bipolar disorder.
Studies published up to October 2003 were evaluated. Those selected for review were controlled trials that used samples of adults with a diagnosis of bipolar disorder and that measured adherence to either mood-stabilizing medication or psychotherapy. Information was extracted on the diagnostic composition and size of the study group, the type and duration of the intervention, the method of measuring adherence, and outcomes.
Eleven studies met inclusion criteria. Although the literature on enhancing treatment adherence among persons with bipolar disorder is limited, the existing data are promising and demonstrate development over time in our understanding of how best to manage this illness. Interventions that have been shown to be effective include interpersonal group therapy, cognitive-behavioral therapy, group sessions for partners of persons with bipolar disorder, and patient and family psychoeducation. Effective therapies occur in the context of long-term management of illness that incorporates a good understanding of medications and their risks and benefits as well as education about illness awareness and self-management. The majority of effective therapies feature an interactional component between patients and their care providers or therapists.
Adherence to treatment for bipolar disorder may be enhanced by interventions that address issues of appropriately taking medications to manage illness. For optimum outcomes, promotion of adherence must be integrated into the medication management of bipolar illness.
由于约三分之一的双相情感障碍患者服药量不足其应服剂量的30%,且不依从治疗与再次住院及自杀相关,因此检索文献以确定关于提高双相情感障碍患者治疗依从性的对照研究。
对截至2003年10月发表的研究进行评估。入选综述的研究为对照试验,其样本为诊断为双相情感障碍的成年人,且测量了对心境稳定剂药物治疗或心理治疗的依从性。提取了关于研究组的诊断构成和规模、干预的类型和持续时间、测量依从性的方法以及结果等信息。
11项研究符合纳入标准。虽然关于提高双相情感障碍患者治疗依从性的文献有限,但现有数据很有前景,并表明随着时间推移我们对如何最佳管理这种疾病的理解有所发展。已证明有效的干预措施包括人际团体治疗、认知行为治疗、针对双相情感障碍患者伴侣的团体会议以及患者及家庭心理教育。有效的治疗发生在疾病的长期管理背景下,这包括对药物及其风险和益处的良好理解以及关于疾病认知和自我管理的教育。大多数有效的治疗都具有患者与其护理提供者或治疗师之间的互动成分。
通过解决合理服药以控制疾病问题的干预措施,可能提高双相情感障碍的治疗依从性。为获得最佳结果,必须将依从性促进纳入双相情感障碍的药物管理中。